Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications

@article{Kondo1999SemisyntheticAA,
  title={Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications},
  author={Shinichi Kondo and Kunimoto Hotta},
  journal={Journal of Infection and Chemotherapy},
  year={1999},
  volume={5},
  pages={1-9}
}
  • S. Kondo, K. Hotta
  • Published 1999
  • Biology, Medicine
  • Journal of Infection and Chemotherapy
Abstract The critical resistance mechanisms of aminoglycoside antibiotics in bacteria of clinical importance are the enzymatic N-acetylation, O-phosphorylation, and O-nucleotidylation that generally result in the inactivation of aminoglycosides. To overcome such resistance mechanisms, dibekacin (3′,4′-dideoxykanamycin B) was developed as the first rationally designed semisynthetic aminoglycoside, based on the enzymatic 3′-O-phosphorylation of kanamycin. Subsequently, amikacin, netilmicin, and… Expand
Amikacin: Uses, Resistance, and Prospects for Inhibition
TLDR
Small molecules as well as complexes ionophore-Zn+2 or Cu+2 were found to inhibit the acetylation reaction and induced phenotypic conversion to susceptibility in bacteria harboring the aac(6′)-Ib gene. Expand
Structural Basis of APH(3′)-IIIa-Mediated Resistance to N1-Substituted Aminoglycoside Antibiotics
TLDR
The structure shows that butirosin A binds to the enzyme in a manner analogous to other 4,5-disubstituted aminoglycosides, and the flexible antibiotic-binding loop is key to the accommodation of structurally diverse substrates. Expand
Novel Aminoglycoside 2″-Phosphotransferase Identified in a Gram-Negative Pathogen
TLDR
Steady-state kinetic studies demonstrated that GTP, and not ATP, is the preferred cosubstrate for APH(2″)-If, which confers resistance to the 4,6-disubstituted aminoglycosides kanamycin, tobramycin, dibekacin, gentamicin, and sisomicin. Expand
Conformations of antibiotics in active sites of aminoglycoside-detoxifying enzymes
TLDR
The extensive use of antibiotics, such as aminoglycosides, over many years, has put tremendous pressure on bacteria, which has responded by conformations of Antibiotics in Active Sites of Aminoglycoside-Detoxifying Enzymes. Expand
Isolation and Thermodynamic Characterization of Aminoglycoside Nucleotidyltransferase (2″)-Ia
Aminoglycoside nucleotidyltransferase(2′′)-Ia (ANT(2′′)) confers resistance to pathogenic bacteria against several aminoglycoside antibiotics including gentamicin, kanamycin and tobramycin. The geneExpand
Plasticity of Aminoglycoside Binding to Antibiotic Kinase APH(2″)-Ia
TLDR
It is found that APH(2″)-Ia maintains a preferred mode of binding aminoglycosides by using the conserved neamine rings when possible, with flexibility that allows it to accommodate additional rings, which explains the low rates of noncanonical phosphorylation activities seen in enzyme assays. Expand
Structural Analysis of the Tobramycin and Gentamicin Clinical Resistome Reveals Limitations for Next-generation Aminoglycoside Design.
TLDR
Two crystal structures of ANT(2″), each in complex with AMPCPP, Mn(2+), and either tobramycin or gentamicin are described, which outline ANT (2″)'s specificity for clinically used substrates and complete structural knowledge for the set of enzymes that most frequently confer clinically observed resistance to tobramYcin and Gentamicin. Expand
Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics.
A series of new hybrid structures containing fluoroquinolone (ciprofloxacin) and aminoglycoside (neomycin) antibiotics linked via 1,2,3-triazole moiety were designed and synthesized, and theirExpand
2-Deoxystreptamine-containing aminoglycoside antibiotics: recent advances in the characterization and manipulation of their biosynthetic pathways.
TLDR
This work focuses on recent advances in the characterization of 2-deoxystreptamine-containing aminoglycosides and their biosynthetic enzymes and pathway as well as some chemo-enzymatic and metabolic engineering approaches for the biological production of natural, semi-synthetic, and novel aminglycosides. Expand
Prospects for circumventing aminoglycoside kinase mediated antibiotic resistance
TLDR
A comprehensive overview of the available APH structures and recent progress in APH inhibitor development is presented, with a focus on the structure-guided strategies. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 50 REFERENCES
The novel enzymatic 3''-N-acetylation of arbekacin by an aminoglycoside 3-N-acetyltransferase of Streptomyces origin and the resulting activity.
TLDR
The results illuminated a novel aspect of arbekacin distinct from the other aminoglycosides, which showed antibiotic activity as high as that of 2'-N-acetylarbekacin reported previously, whereas 3"-N-acetylamikacin showed no substantial activity. Expand
Enzymatic 2'-N-acetylation of arbekacin and antibiotic activity of its product.
TLDR
It is believed 2'-N-acetyl ABK has the highest and broadest antibacterial activity, compared with known N- acetylated AGs. Expand
BB-K 8, a new semisynthetic aminoglycoside antibiotic.
TLDR
BB-K8 is a new derivative of kanamycin acylated with L(-)-γ-γ-amino-α-hydroxybutyric acid at the C-1 amino group of the 2-deoxystreptamine moiety that has antibacterial activity generally equal to Kanamycin againstkanamycin-sensitive organisms and is also active against kan amycin- and/or gentamicin-resistant organisms, including Pseudomonas strains. Expand
Biochemical mechanism of resistance to aminoglycosidic antibiotics.
  • H. Umezawa
  • Chemistry, Medicine
  • Advances in carbohydrate chemistry and biochemistry
  • 1974
TLDR
The chapter proves the direct relationship between the enzymes and the resistance; this was first shown by the fact that kanamycin C inhibits the resistant strain that produces the enzyme involved in acetylation of the 6´-amino group of kanamycins A and B. Expand
Antibacterial activity and nephrotoxicity of two novel 2″-amino derivatives of arbekacin
TLDR
Results indicate that the 2″-amino group introduced to ABK confers high stabilization to the aminoglycoside-modifying enzymes, while reducing acute and renal toxicities. Expand
A newly recognized acetylated metabolite of arbekacin in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus.
TLDR
A newly recognized metabolite of arbekacin in arbekACin-resistant strains of MRSA is described, which is shown to be the bifunctional aminoglycoside-modifying enzyme, aminglycoside phosphotransferase (APH(2 ))–aminoglycosid acetyltransferase (AAC(6 )), which simultaneously phosphorylates and acetylates. Expand
Tobramycin adenylyltransferase: a new aminoglycoside-inactivating enzyme from Staphylococcus epidermidis.
Certain strains of Staphylococcus epidermidis resistant to the aminoglycoside antibiotics were shown to contain an enzyme that inactivates the kanamycins, neomycins, butirosins, paromomycin,Expand
Enzymatic Modification of Aminoglycoside Antibiotics: 3-N-Acetyltransferase with Broad Specificity that Determines Resistance to the Novel Aminoglycoside Apramycin
  • Julian Davies, S. O'Connor
  • Biology, Medicine
  • Antimicrobial Agents and Chemotherapy
  • 1978
Examination of a number of R-plasmid-containing bacterial isolates of animal origin has revealed the presence of a new aminoglycoside acetyltransferase (3-N) with a broad substrate range thatExpand
Structures and syntheses of aminoglycoside antibiotics.
  • S. Umezawa
  • Chemistry, Medicine
  • Advances in carbohydrate chemistry and biochemistry
  • 1974
Publisher Summary This chapter discusses the structure and synthesis of aminoglycoside antibiotic. The chemistry of individual sugars present in antibiotic has been reviewed along with sugarsExpand
Studies on Aminosugars. XXIX. The Synthesis of 3′-O-Methylkanamycin
6-O-(3-Amino-3-deoxy-α-D-glucopyranosyl)-2-deoxystreptamine, previously synthesized, was masked with ethoxycarbonyl, isopropylidene, and benzyl groups to giveExpand
...
1
2
3
4
5
...